News About: R&D
Bill will be prepared for KPA’s ethics commission to make request to revoke license
A bill will be prepared to allow the Korean Pharmaceutical Association(KPA) Ethics Commission to make a request to the Ministry of Health and Welfare to cancel the license of pharmacist who are diagnosed mental illnes...
Biobetter jointly developed with Ildong, ‘ublituximab’ completed part 1 of Phase 2 clinical trial
The development of ‘ublituximab(TG-1101),’ a TG Therapeutics’ monoclonal antibody biobetter, jointly conducted with Ildong Pharmaceutical(CEO Woong-Seup Yoon), passed the part 1 of the Phase 2 clinical trial in the U....
KDRA & KIRAMS sign ‘New Drug Development Agreement’
The Korea Drug Research Association(Chairman Dong-Yeon Kim, KDRA) and the Korea Institute of Radiological & Medical Sciences’(KIRAMS) Advanced Concept Medical Technology Development Platform Building Project Team(Team...
‘Remote dispenser’ completed with examination, to be introduced to vice ministers’ meeting
The Office of Legislation’s examination for remote drug dispensers was finished. Their name was officially finalized as ‘Video Drug Vending Machine.’
According to the Ministry of Health and Welfare(MFDS), the Office ...
Alteogen challenges to KRW 2 trillion hemophilia biomedicine ‘NovoSeven’
Alteogen Inc.(CEO Soon-Jae Park) held an agreement ceremony on the 29th of November as its long-acting hemophilia treatment being developed, ‘ALT-Q2,’ was selected as a project to develop a substance candidate for a p...
Nature Cell acquires approval of Phase 1/2 clinical trials for dementia treatment from US FDA
Clinical trials to treat American Alzheimer’s disease patients with stem cells manufactured in Korea were approved by the U.S. FDA.
Nature Cell(CEO Jung-Chan La) announced it acquired approval of the Astrostem’s Phas...
Development trend in modified drugs, ‘complex antidiabetics’
The Korean pharmaceutical companies’ development trend of modified drugs was analyzed as development of complex antidiabetics.
According to the Ministry of Food and Drug Safety’s Online Drug Library, the number of dr...
What are vaccines to keep eye on for shingles?
The number of shingles patients has been increasing, and most of them are actually the middle-aged and elders. Thus, companies actively developing vaccines seem to be busy proving rate of prevention in the elder group...
“Once remote medicine dispensers are implemented, they will eventually be managed by call centers”
“If the door of remote medicine dispenser opens, the function of pharmacists will be destroyed. Even though there will be lots of restrictions soon, it will be spoiled in various forms through future law amendments, w...
Clear opinion differences between Sanofi vs LG over ‘Zemiglo’
The outline of the lawsuit over ‘Zemiglo,’ an antidiabetic developed by LG Life Sciences, became visible.
The first defense for the damage suit filed by the previous seller of Zemiglo, Sanofi-Aventis Korea, against...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
